Loading provider…
Loading provider…
Hematology & Oncology Physician in Truckee, CA
NPI: 1467438358Primary Practice Location
TAHOE FOREST HOSPITAL
10121 Pine Ave, Truckee, CA
Primary Employer
Tahoe Forest Multispecialty Clinics
tfhd.com
HQ Phone
Get M.D., M.A.S. Thomas's Phone Numberphone_androidMobile
Get M.D., M.A.S. Thomas's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2005 - 2027
NV State Medical License
2023 - 2027

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Rush Medical College
rushu.rush.edu
Medical School
Until 2004
University of California Davis Health
Fellowship • Hematology and Medical Oncology
2007 - 2010
Residency • Internal Medicine
2004 - 2007
Authors: Primo Lara, Barbara Gitlitz
Journal: J Thorac Oncol
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.
Authors: Gregory Masters, Perry Guaglianone, Anand Karnad, Lyudmila Bazhenova, Kurt Oettel, Charles Blanke
Publication Date: 2017-06-29
Authors: David Gandara, Karen Kelly, Karen Kelly
Journal: Clin Lung Cancer
Publication Date: 2021-10-10
Lead Sponsor: Edward Kim
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Oxaliplatin, DRUG: Carbon C 14 Oxaliplatin
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Cyclosporine, DRUG: Selumetinib
Lead Sponsor: University of California, Davis
Collaborators: National Cancer Institute (NCI), Millennium Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: irinotecan hydrochloride, DRUG: alisertib